₨ NPR
Description
ZANTOR 40 is a prescription medication containing Febuxostat 40 mg, produced by Quest Pharmaceuticals Pvt. Ltd. It is primarily used to manage hyperuricemia (elevated uric acid levels in the blood) and prevent gout flare-ups.
🧪 Category
-
Antihyperuricemic Agent
-
Xanthine Oxidase Inhibitor
💊 Primary Uses
-
Gout Management: Reduces uric acid levels to prevent gout attacks.
-
Hyperuricemia Treatment: Manages high uric acid levels, especially in patients undergoing chemotherapy for blood cancers.
⚙️ How It Works
Febuxostat inhibits the enzyme xanthine oxidase, which is responsible for converting purines into uric acid. By blocking this enzyme, the medication lowers uric acid production, thereby reducing the risk of gout attacks and other complications associated with high uric acid levels.
⚠️ Common Side Effects
-
Nausea
-
Joint pain
-
Liver function abnormalities
-
Rash
-
Dizziness
Note: Serious cardiovascular events have been reported in some cases. Regular monitoring and consultation with a healthcare provider are essential.
📌 Dosage & Administration
-
Initial Dose: 40 mg once daily.
-
Maintenance Dose: May be increased to 80 mg daily if serum uric acid levels remain above 6 mg/dL after two weeks.
-
Administration: Can be taken with or without food.
🔒 Precautions
-
Liver Impairment: Use with caution; dosage adjustments may be necessary.
-
Cardiovascular Risk: Patients with a history of heart disease should discuss potential risks with their doctor.
-
Drug Interactions: Inform your healthcare provider about all medications you are taking to avoid potential interactions
Reviews
There are no reviews yet.